Pharmacy Technicians, Advanced Techs Can Do More in the Pharmacy
Pharmacy Times
MARCH 24, 2024
Studies have shown that the presence of advanced pharmacy technicians in a pharmacy has a positive predictive validity to increased monthly immunizations.
Sat.Mar 23, 2024 - Fri.Mar 29, 2024
101 
Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration
Drug Topics
MARCH 27, 2024
At APhA 2024, 2 posters looked into how collaboration between physicians and community pharmacists is crucial when it comes to opioid prescriptions, and current opioid use patterns among older adults.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What States are Doing to Regulate Pharmacy Benefit Managers
Drug Topics
MARCH 25, 2024
In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.
Navigating the Psychedelic Renaissance: Emerging Mental Health Therapies and the Pharmacist’s Role
Pharmacy Times
MARCH 27, 2024
Psychedelic medicines such as psilocybin, MDMA, ketamine, and LSD have been shown to have a significant impact on conditions such as major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder in clinical trials.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Examining Antibiotic Allergies, Pharmacists Role in Testing
Drug Topics
MARCH 25, 2024
Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
STAT
MARCH 28, 2024
While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary. His former student Ali Ellebedy was gnawed by frustration as Covid shutdowns stalled his influenza research; it took until the summer, when mass vaccination planning hit his radar, before the same realization kicked in.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Pharmacist's Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education
Pharmacy Times
MARCH 23, 2024
Shared decision making with patients is a key component of RSV vaccination, which can bring challenges and opportunities.
Demographics Significantly Influence Common Customer Behavior at Community Pharmacies
Drug Topics
MARCH 29, 2024
Researchers found various reasons for why individuals chose a specific pharmacy and how they purchase OTC medication.
How expanded methadone access helped Switzerland defuse its drug crisis
STAT
MARCH 26, 2024
ZURICH — The lobby of this addiction clinic is unremarkable, really, except for the network of metal chutes and tubes that hug the walls as they snake downward from a pharmacy on the upper floors. Every few minutes, a new prescription comes clattering down, delivering a bottle full of powerful and effective pills used to treat opioid addiction to a waiting patient at the front desk.
BioNTech hit with 'notice of default' from NIH in COVID-19 vaccine royalty dispute
Fierce Pharma
MARCH 25, 2024
Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. | Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults
Pharmacy Times
MARCH 27, 2024
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
Improving CVD Outcomes Through Better Recommendations, Patient Monitoring
Drug Topics
MARCH 27, 2024
Researchers detailed the FDA’s recommendations on low-dose aspirin and pharmacists’ role in cardiovascular practice transformation programs.
Why researchers think human milk could repair the gut microbiome and reduce infections
STAT
MARCH 29, 2024
For babies who are breastfed, their first source of sustenance is filled with proteins, sugars, hormones, vitamins, and minerals — just the right amount of nutrients for an infant. That milk could also lower the risk of asthma , diabetes, and allergies. And it could make low-birth-weight, preterm babies up to 10 times less likely to develop necrotizing enterocolitis , a common intestinal disorder.
Diabetes management tools not worth the cost, study finds. But digital health companies push back on 'flawed' analysis
Fierce Healthcare
MARCH 24, 2024
A new analysis pours cold water on the effectiveness of widely used digital diabetes management solutions, stirring up discussion about how best to evaluate the growing market of digital health too | The Peterson Health Technology Institute's analysis assessed whether digital diabetes solutions improve users' health outcomes over "usual care.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Changing Mindset Is Crucial for Clinicians to Effectively Implement New Weight Management Medications
Pharmacy Times
MARCH 23, 2024
In addition to improved efficacy, newer generations of anti-obesity medications have significantly improved safety concerns.
Ozempic, Other GLP-1 Therapies Caused Major Increase in Medicare Spending
Drug Topics
MARCH 29, 2024
After semaglutide and tirzepatide were approved, and ozempic use continues to rise, Medicare spending is also increasing because of a high demand for GLP-1 therapies.
STAT+: Why the world’s most expensive drug might not be all that overpriced
STAT
MARCH 28, 2024
The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason. But last year, its staff sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’
How Amazon Pharmacy is using AI to deliver medications faster as it expands same-day delivery
Fierce Healthcare
MARCH 26, 2024
Amazon Pharmacy expanded its same-day medication delivery service to New York City and Los Angeles, with plans to add a dozen more U.S. | Amazon Pharmacy expanded its same-day medication delivery service to New York City and Los Angeles, with plans to add a dozen more U.S. cities by the end of the year, the company announced Tuesday.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Vitamin A Derivative May Have a Significant Role in Wound Healing
Pharmacy Times
MARCH 25, 2024
Vitamin A regulates stem cell differentiation to manage wound healing, although risk of tumor growth may increase if differentiation does not occur.
BD to Increase Plastic Syringe Production After FDA Warns on Imports From China
Drug Topics
MARCH 28, 2024
Following quality concerns voiced by the FDA regarding plastic syringes made in China, medical technology company BD has announced it will increase its production of plastic syringes in the US.
STAT+: Some nonprofit hospitals spend less on charity care than they receive in tax breaks, new analysis shows
STAT
MARCH 26, 2024
A new study of hospitals’ charity care spending suggests nonprofit hospitals really aren’t that different from their for-profit counterparts. One major benefit of being a nonprofit hospital is receiving tax exemptions on property taxes, income taxes, and sales taxes. Experts told STAT that implies a “social contract” with taxpayers, where these hospitals will help take care of the most vulnerable.
'Things get built and forgotten about': The challenging work of maintaining AI tools in clinical settings
Fierce Healthcare
MARCH 29, 2024
With AI being all the buzz in healthcare today, many questions about the technology still remain. Do clinicians understand and trust AI tools? Are algorithms accurate and free from bias? | At the 2024 SXSW conference, a panel on the future of AI in healthcare moderated by AMA President Jesse Ehrenfeld, M.D., discussed what's still needed for safer, more integrated and more impactful systems.
Understanding DSCSA: Insights for All Dispensers
Pharmacy Times
MARCH 28, 2024
As the full act will be enforced in November 2024, all medication dispensers must ensure they’re fully prepared.
Moderna’s Next-Gen COVID-19 Vaccine Outperforms Spikevax in Phase 3 Trial
Drug Topics
MARCH 27, 2024
mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
STAT
MARCH 25, 2024
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines , which have saved millions of lives. You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective.
Contract negotiations between Providence, Blue Shield of California go publicly south
Fierce Healthcare
MARCH 25, 2024
Providence has launched the first public salvo in a spat with Blue Shield of California over ongoing contract negotiations. | Providence has launched the first public salvo in a spat with Blue Shield of California over ongoing contract negotiations.
Pharmacy Focus: Policy Edition - Overview of California's Stop Dangerous Pharmacies Act
Pharmacy Times
MARCH 27, 2024
Ron Lanton discusses California's Stop Dangerous Pharmacies Act, which aims to address understaffed chain pharmacies and reduce medication errors by implementing new regulations around pharmacy staffing, error reporting, and unsafe working conditions.
Assessing How COVID-19 Impacted Pharmacists’ Work Activities, Job Satisfaction
Drug Topics
MARCH 27, 2024
Two posters presented at APhA 2024 examined how the COVID-19 pandemic impacted pharmacists and their work.
Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments
STAT
MARCH 27, 2024
For years, researchers have been hopeful they could get under the hood of multiple sclerosis. The neurological condition shows up in over 2.5 million people around the world, but it doesn’t always look the same. If science could point its light in just the right way, patients might be sorted into disease subgroups, and treated more successfully depending on their kind of MS.
Intelligence officials warned lawmakers WuXi AppTec furnished China with client's intellectual property: Reuters
Fierce Pharma
MARCH 28, 2024
An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. | An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. suggests intelligence officials and lawmakers may have good reason to be concerned about the CDMO’s potential political ties to its home country.
FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients
Pharmacy Times
MARCH 25, 2024
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
High Frequency of OTC Product Misuse in Older Adults Highlights Areas for Pharmacists to Address
Drug Topics
MARCH 23, 2024
Adults aged 65 years and older are the largest group of consumers of OTC medications.
GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable
STAT
MARCH 29, 2024
Diabetes drugs are too expensive in the U.S., and insulin is infamously six to 13 times more expensive here than in comparable high-income countries. And blockbuster GLP-1 drugs, too, could be a lot less expensive, according to an investigation published this week in JAMA Network Open, with a simple change: robust generic competition. The study, led by Melissa Barber, a Yale postdoctoral fellow, and conducted in collaboration with Doctors Without Borders, a nonprofit medical organization working
Let's personalize your content